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ABSTRACT OF THESIS 
 
TIME-DEPENDENCE OF DISTAL-TO-PROXIMAL HIPPOCAMPAL 
NEURODEGENERATION PRODUCED BY N-METHYL-D-ASPARTATE 
RECEPTOR ACTIVATION  
 
Excitotoxicity is the overexcitation of neurons due to the excessive activation of 
excitatory amino acid receptors and is thought to be involved in many neurodegenerative 
states.  The manner in which the neuron breaks down during excitotoxicity is still 
unclear.  The current study used the organotypic hippocampal slice culture model to 
examine the time-dependent loss of the synaptic vesicular protein synaptophysin and the 
loss of N-methyl-D-aspartate (NMDA) receptor NR1 subunit availability following an 
excitotoxic insult (20 µM NMDA) to provide a better understanding of the topographical 
nature of neuronal death following NMDA receptor activation. Significant NMDA-
induced cytotoxicity in the CA1 region of the hippocampus (as measured by propidium 
iodide uptake) was evident early (15 minutes after exposure) while significant loss of the 
NR1 subunit and synaptophysin was found at later timepoints (72 and 24 hours, 
respectively), suggesting delayed downregulation or degradation in axons and dendrites 
as compared to the soma.  The addition of the competitive NMDA receptor antagonist 2-
amino-7-phosphonovaleric acid (APV) significantly attenuated all NMDA-induced 
effects.  These results suggest that NR1 and synaptophysin levels as measured by 
immunoreactivity are not reliable indicators of early cell death.   
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Chapter One 
Introduction 
Background 
Excitotoxicity is the overexcitation of neurons due to the excessive activation of 
excitatory amino acid receptors and is thought to be involved in many neurodegenerative 
states, including traumatic brain injury (TBI), ischemia, stroke, epilepsy, and 
amyotrophic lateral sclerosis, ALS (see Choi, 1992 for a review).  In addition, it is 
thought to be a factor in mediating the degenerative effects of alcohol withdrawal.  It is 
estimated that there were over 1.5 million cases of TBI in the United States in 2003, with 
more than 50,000 deaths (Rutland-Brown, Langlois, Thomas, & Xi, 2006).  Recent 
advances in the medical practices of developed countries have lowered the rate of 
incidence for hypoxic/ischemic events to 1-2 per 1000 live births, with a mortality rate of 
10-20% (Verklan, 2009).  Likewise, although the number of hospitalizations for a stroke 
decreased from 833,000 in 1997 to 726,000 in 2004 (Fang, Alderman, Keenan, & Croft, 
2007), stroke is still listed as the third leading cause of death in the United States.  The 
2007 Substance Abuse and Mental Health Services Administration (SAMHSA) National 
Survey of Drug Use and Health reported that over 50% of people age 12 and older 
admitted to drinking alcohol within the last 30 days.  Furthermore, over 1/5 of Americans 
age 12 and older reported past month binge use of alcohol, defined as five or more drinks 
on one occasion (Substance Abuse and Mental Health Services Administration, 2008).  
Given the wide range of effects on cellular integrity associated with excitotoxicity and 
the large number of people affected each year, uncovering the mechanisms by which 
excitotoxicity causes damage is one of the goals of many researchers today, as it can have 
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implications in a host of various degenerative conditions.  In particular, the amino acid 
glutamate and it’s receptors are thought to be critical in mediating the damaging effects 
of excitotoxicity.   
 
Glutamate Receptors: Structure and Function 
 Glutamate is the major excitatory neurotransmitter in the mammalian brain and 
activates both ionotropic and metabotropic receptors.  While the glutamate metabotropic 
receptors produce actions via G-proteins (linked to these receptors) to possibly release 
intracellular stores of calcium (Ca2+), glutamate ionotropic receptors act via ion channels 
to allow sodium (Na+), potassium (K+), and/or Ca2+ to flow into the cell.  The 
glutamatergic ionotropic family of receptors includes the kainate receptor, the 2-amino-
3(3-hydroxy-5-methylisoxazol-4-yl) proprionate (AMPA) receptor, and the N-methyl-D-
aspartate (NMDA) receptor. 
 AMPA receptors are heteromeric structures composed of four different subunits, 
GluR1-4, which usually combine to form heterotetramers.  Each subunit consists of a 
membrane region with three transmembrane domains (TM1, 3, and 4) and a second 
domain which loops back within the membrane and comes out the intracellular side (M2).  
Thus, each subunit has an extracellular N-terminal domain and an intracellular C-terminal 
domain.   Of the four subunits, it is only the GluR2 subunit that can undergo RNA editing 
in the second membrane to produce a positively charged arginine (R) residue as opposed 
to the neutral glutamine (Q) residue that is present on unedited GluR2 subunits (Jonas & 
Burnashev, 1995).  This editing of the GluR2 subunit mediates the receptor’s 
permeability to Ca2+ and other ions (Jonas & Burnashev, 1995).   In particular, receptors 
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missing the GluR2 subunit exhibit a high permeability to Ca2+ and other cations while 
receptors containing the edited GluR2 and therefore the arginine residue are impermeable 
to Ca2+ (Jonas & Burnashev, 1995).  Previously it was thought that all AMPA receptors 
were impermeable to Ca2+; however, it is now known that this is not the case as AMPA 
receptor antagonists have now been shown to be neuroprotective against excitotoxicity 
(for a review, see Gill & Lodge, 1997).   The AMPA receptor is blocked by polyamines 
under resting conditions and is only opened when the membrane becomes depolarized to 
reach the threshold for an action potential.  Once the polyamine blockade is removed, the 
ion channel opens to allow Na+ (and Ca2+, if applicable) into the cell.  This further 
depolarizes the cell and can lead to activation of the NMDA receptor as AMPA and 
NMDA receptors are often co-localized in the cell membrane.  This close proximity 
between AMPA and NMDA receptors is important in memory processes such as long-
term potentiation (LTP) and long-term depression (LTD; (for a review, see Wheal, et al., 
1998).   
The kainate receptors, although not yet well characterized, are thought to be made 
up of tetramers comprised of various subunits including GluR5-7 and KA1-2 (for a 
review, see Heath & Shaw, 2002).   Structurally, each subunit is thought to be 
homologous to the subunits of the AMPA receptor (Sattler & Tymianski, 2001).  The 
GluR5-7 subunits have a relatively low affinity for kainate compared to the high-affinity 
KA1 and KA2 subunits (reviewed in Lodge, 2009).  The high-affinity KA1 and KA2 
receptor subunits cannot form functional receptors alone but can combine with GluR5 or 
GluR6 to form functional receptors (Lodge, 2009).  Similar to the GluR2 subunit of the 
AMPA receptor, GluR5 and GluR6 can undergo RNA (Q/R) editing in transmembrane 
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domain 2; this editing is thought to mediate the channel’s permeability to Ca2+ (Pinheiro 
& Mulle, 2006).  The kainate receptors have been shown to both facilitate and inhibit the 
synaptic release of glutamate when kainate receptors are found on the presynaptic nerve 
cell and thus serve as autoreceptors (see Jane, Lodge, & Collingridge, 2009 for a review).   
 NMDA receptors are ionotropic glutamate receptors which are tetramers made up 
of two essential NR1 subunits and two regulatory subunits composed of NR2A-D and/or 
NR3A-B subunits, although NR2A and NR2B are the most commonly expressed 
regulatory subunits (for a review, see Cull-Candy, Brickley, & Farrant, 2001).  
Structurally, the subunits are similar to AMPA receptor subunits, each possessing four 
membrane domains (3 transmembrane-spanning domains and one membrane domain that 
loops back around), an extracellular N-terminal domain, and an intracellular C-terminal 
domain (as reviewed in Paoletti & Neyton, 2007).  The ion channel is blocked (voltage-
dependently) by Mg2+, which is removed via membrane depolarization to allow Ca2+ and 
a small amount of Na+ into the cell (Lynch & Guttmann, 2001).  As noted earlier, AMPA 
receptor depolarization is a common mechanism by which the Mg2+ blockade is removed.  
Glycine serves as a co-agonist at the NMDA receptor and must be bound to the NR1 
subunit before the receptor is fully activated; however, the glutamate binding site is 
located on the NR2 subunit and must also be bound (Paoletti & Neyton, 2007).  Thus, the 
opening of the NMDA receptor ion channel requires three distinct events: removal of the 
Mg2+ blockade, glycine binding, and glutamate binding (Lynch & Guttmann, 2001).  
Polyamines, protons, and extracellular Zn2+ also act allosterically to modify receptor 
selectivity (Cull-Candy, et al., 2001).  NMDA antagonists, such as MK-801, ketamine, 
4 
 
and phencyclidine (PCP), are ion channel blockers which are non-competitive with 
NMDA (Lynch & Guttmann, 2001).   
The NR1 subunit has a total of eight functional splice variants, each of which has 
a different sensitivity to agonist, antagonists, Ca2+ and other ions, as well as one 
nonfunctional splice variant (see Zukin & Bennett, 1995 for a review).  An asparagine 
residue (N598) found on the second membrane domain on both NR1 and NR2 subunits 
regulates the permeability to Ca2+, Mg2+, Na+, polyamines, and Zn2+, with contrasting 
effects on the NR1 and the NR2 subunit (Burnashev, et al., 1992; Schneggenburger & 
Ascher, 1997; Traynelis, Burgess, Zheng, Lyuboslavsky, & Powers, 1998).  Specifically, 
replacing the asparagine residue with a glutamine residue on the NR1 was found to 
slightly reduce the Mg2+ blockade and decrease Ca2+ permeability, while the same 
replacement on the NR2 did not significantly affect Ca2+ permeability but did increase 
Mg2+ permeability and more strongly reduced the Mg2+ blockade (Burnashev, et al., 
1992).   
While the NR2 and NR3 subunits are regulatory, the NR1 subunit is essential for 
functional NMDA receptors. Genetic deletions of the NR1 subunit have proven to be 
lethal within the early postnatal period (Forrest, et al., 1994).  In contrast, deletion of the 
NR2A subunit in mice resulted in survival and normal developmental appearance 
(Sakimura, et al., 1995).  Previous research has also shown the NR1 subunit to be 
essential for immediate glutamate and NMDA-mediated toxicity (Tokita, et al., 1996).  
Alongside the various sensitivities of the NR1 receptor, each NR2 subunit also has 
distinctive sensitivities which give rise to the many combinations of various receptor 
subtypes.  Specifically, the NR2 receptor subunits each exhibit different sensitivities to 
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the Mg2+ block, glycine, and glutamate affinity (Kutsuwada, et al., 1992; Monyer, et al., 
1992; Stern, Behe, Schoepfer, & Colquhoun, 1992).   
Each NMDA receptor subunit demonstrates differences in their intracellular C-
terminal domain sequence, which is thought to mediate the interaction of the NMDA 
receptor and various intracellular cytoskeletal and synaptic proteins (for reviews, see 
Arundine & Tymianski, 2004; Forder & Tymianski, 2009).  The NMDA receptor and 
related proteins make up a large multiprotein structure located beneath the postsynaptic 
membrane known as the postsynaptic density (PSD).  Postsynaptic density proteins are 
involved in various functions, including regulation of receptor clustering, modulation of 
receptor function, and cell to cell bonding (Forder & Tymianski, 2009).  Moreover, there 
are four key types of molecules within the PSD including cytoskeletal, membrane-bound, 
modulatory enzymes, and scaffolding proteins (Forder & Tymianski, 2009).  The 
interactions between the NMDA receptor and PSD proteins are highly specific, indicating 
that these interactions connect NMDA receptor to particular downstream signaling 
molecules (Arundine & Tymianski, 2004).    
 
Glutamate Receptors and Excitotoxicity 
In early studies by Lucas and Newhouse (1957), glutamate injections into the 
mouse retina were found to be toxic, thus suggesting that glutamate may be a neurotoxin.  
Later experiments by Olney (1982) showed that excessive glutamate within the retina 
resulted in damage to the dendrosomal, but not the axonal, part of a neuron.  Thus, Olney 
further postulated that since most neurons within the CNS contain one or more subtypes 
of excitatory amino acid (EAA) receptors on the dendrite or the soma, it is likely that 
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neurodegeneration due to overactivation of EAA receptors is often seen in the dendrites 
and the soma rather than in the axon (Olney, 1994).  It was also Olney (1986) who first 
coined the term excitotoxicity, referring to neurodegeneration via overexcitation of 
postsynaptic ionotropic EAA receptors.  Further, research has shown that magnesium, 
which attenuates synaptic activity, can reduce the damage associated with anoxic/hypoxic 
injury (Kass & Lipton, 1982; Rothman, 1983).  More recently it has been shown that 
glutamate NMDA receptor antagonists such as 2-amino-7-phosphonovaleric acid or 2-
amino-7-phosphonohepatonic acid (APV) and MK-801 given prior to the insult can 
protect against ischemic-induced damage (Ozyurt, Graham, Woodruff, & McCulloch, 
1988; Simon, Swan, Griffiths, & Meldrum, 1984).  
Choi and colleagues (1987) found that cortical cell cultures exposed briefly to  
glutamate resulted in rapid morphological changes.  These changes were then followed 
by overall neuronal degeneration (Choi, et al., 1987).  Indeed, it is the NMDA glutamate 
receptor, not the metabotropic, AMPA, or kainate receptors, that has been implicated as 
the main cause of excitotoxicity within the brain (Choi, 1992).  Glutamate-mediated 
excitotoxicity results in an array of destructive changes within the cell, including swelling 
and neuronal degeneration (Choi, 1992).  Complete blockade of the NMDA receptor is 
not a viable option to treat the effects of excitotoxicity, as this attempt failed during 
stroke trials (Davis, et al., 2000) and can be harmful to animals (Fix, et al., 1993).  
Recently, however, research has been focused on the downstream effects associated with 
excitotoxicity, such as the production of harmful reactive oxygen species (ROS) 
including superoxide, nitric oxide (NO) and peroxynitrite (for a review, see Forder & 
Tymianski, 2009).  Nitric oxide is known to be an important messenger molecule in 
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several processes, but was also found to be generated following glutamate exposure via 
NMDA receptor activation in primary cortical cell cultures (Dawson, Dawson, London, 
Bredt, & Snyder, 1991).  The same study found that NOS inhibitors completely blocked 
the excitotoxic effects of NMDA (Dawson, et al., 1991).  Post-synaptic density  proteins 
have also been investigated as possible mechanisms by which excitotoxicity can be 
reduced (Forder & Tymianski, 2009).  Within the PSD domain, the protein PSD-95 plays 
an important structural role in connecting the NMDA receptor with signaling enzymes 
and intracellular proteins (Forder & Tymianski, 2009).  A recent review suggested that 
PSD-95 inhibitors may be useful in the treatment of brain damage as a result of severe 
hyperthermia as well as ischemic insult, if given within hours of the insult, and could be 
useful in the treatment of stroke as well (Forder & Tymianski, 2009).   
 
Glutamate-mediated Excitotoxicity: The Role of Calcium 
One important ion intimately linked to the damaging effects of excitotoxicity is 
calcium (Ca2+), which is also critical to many cellular processes, including cell growth 
and differentiation as well as synaptic movement.  Neurons are able to control the 
intracellular Ca2+ concentration and the flow of Ca2+  ions via the interactions of Ca2+ 
influx, Ca2+ efflux, Ca2+ buffering, and internal Ca2+ storage (Sattler & Tymianski, 2000).  
A pioneer study by Schanne and colleagues discovered that hepatocyte survival was 
dependent on whether the membrane toxin contained Ca2+ (Schanne, Kane, Young, & 
Farber, 1979).   
Although small, physiologically relevant amounts of Ca2+ are necessary for the 
cell to function properly, excessive Ca2+ influx can overcome regulatory mechanisms and 
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activate a number of enzymes, including proteases, phospholipases, and endonucleases, 
eventually leading to cell death  (Choi, 1995; Sattler & Tymianski, 2000).  Proteases, 
such as calpains, are Ca2+-activated enzymes which have been shown to be mediated by 
glutamate receptor activation and can degrade several structural proteins, including 
microtubule-associated proteins, tubulin, and spectrin (Siman & Noszek, 1988).  Thus, 
proteases destroy the cell via breakdown of the cytoskeleton.  An earlier study by Siman 
and colleagues found that EAA-induced calpain I activation is closely associated with 
EAA-induced hippocampal damage since only those doses of EAAs which produce 
hippocampal damage also result in calpain I activation (Siman, Noszek, & Kegerise, 
1989).  Increased Ca2+ levels can also activate phospholipases, enzymes which hydrolyze 
phospholipids into fatty acids, which can produce arachidonic acid and lead to the 
production of free radicals (Sattler & Tymianski, 2000).  Moreover, elevated Ca2+ levels 
can activate endonucleases, enzymes which cleave the phosphodiester bond, which can 
lead to DNA degradation (Sattler & Tymianski, 2000).  Increased cytosolic Ca2+ can also 
work in conjunction with diacylglycerol to activate protein kinase C, which can lead to 
further Ca2+ release from intracellular stores such as the endoplasmic reticulum (Choi, 
1988).  Furthermore, elevated intracellular Ca2+ levels can also activate Ca2+-binding 
proteins such as calmodulin to produce NO synthase (cytochrome P450-related 
enzymes), which can then produce NO, and eventually leads to the production of 
peroxynitrite (ONOO-) and cell death (Nicotera & Orrenius, 1998; Sattler & Tymianski, 
2000).  In addition, the Ca2+/calmodulin-regulated protein phosphotase calcineurin is 
activated by Ca2+ influx.  Calcineurin inhibitors (i.e. cyclosporine A and FK-506) have 
been shown to be neuroprotective against the early necrotic and apoptotic effects of high 
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glutamate exposure (Ankarcrona, Dypbukt, Orrenius, & Nicotera, 1996).  The same study 
also found that cyclosporine A prohibited the breakdown of the mitochondrial membrane 
potential which is normally associated with glutamate-induced necrosis (Ankarcrona, et 
al., 1996).  Recently, it has been shown that the axonal damage induced by excessive 
glutamate is mediated by the cleavage or phosphorylation of the collapsin response 
mediator protein 2 (CRMP2) via activation of calpain or the Ca2+/calmodulin dependent 
protein kinase II (CaMKII), respectively (Hou, et al., 2009). 
Interestingly, not all influxes of Ca2+ are damaging to the cell.  The source-
specificity hypothesis was established based on previous experiments showing that 
Ca2+influx via L-type voltage-sensitive Ca2+ channels were not harmful to the cell while 
the same amount of influx via NMDA receptors resulted in cytotoxicity (Sattler, 
Charlton, Hafner, & Tymianski, 1998; Tymianski, Charlton, Carlen, & Tator, 1993).  
Thus, the location of Ca2+ entry and subsequent activation of signaling pathways 
mediates the toxicity associated with elevated Ca2+ levels.  It has been postulated that 
Ca2+  influx via the NMDA receptor results in high Ca2+ concentrations in the vicinity of 
specific signaling molecules which have been linked to the NMDA receptor, thus 
initiating distinct cell death pathways (Sattler, et al., 1998).  The destructive pathways 
have also been shown to be more easily activated when the Ca2+ influx is due to 
glutamate receptors which have specialized entry points (Arundine & Tymianski, 2004). 
Berdichevsky and colleagues were the first to suggest that increased Ca2+ may be 
the mechanism mediating the damaging effects of both NMDA and glutamate exposure 
(Berdichevsky, Riveros, Sanchez-Armass, & Orrego, 1983).  Choi (1985) expanded this 
theory by studying the effects of removing extracellular Na+ and extracellular Ca2+ 
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following a brief glutamate exposure in cortical cell cultures.  Results showed that 
removing extracellular Na+ produced an immediate reduction in neuronal loss, but only a 
minor reduction in loss measured 24 hours later (Choi, 1985).  In contrast, removing 
extracellular Ca2+ produced little immediate changes in cell death but marked reductions 
in neuronal loss measured 24 hours later (Choi, 1985).  However, not all researchers 
agreed that Ca2+ was the main mediator behind glutamate neurotoxicity.  One early study 
found that acute glutamate toxicity in the chick embryo retina was dependent on Na+ and 
Cl-, but not Ca2+ (Olney, Price, Samson, & Labruyere, 1986).  However, as the authors 
suggest, Ca2+ may play a role in mediating the more delayed effects of glutamate 
neurotoxicity (Olney, et al., 1986).   
Choi (1987) first suggested that glutamate-mediated neurotoxicity can be divided 
into two components.  The first stage involves neuronal swelling, depends on Na+ and Cl- 
extracellular concentrations, can be mimicked by high K+, and occurs early.  The second 
stage involves neuronal degeneration, depends on Ca2+, and occurs later.  Choi (1987) 
also suggested that while both components can produce damage, it is the second Ca2+-
dependent component which mediates the damage induced by low glutamate exposure.  
  
Ca2+-mediated Excitotoxicity in Ischemia 
 Calcium-mediated excitotoxicity is often implicated in ischemia-related injury, as 
the Ca2+-mediated death pathways become overactive after ischemic injury.  Initially 
following the ischemic injury, the cellular energy levels decline as a result of decreased 
oxygen and glucose, leading to decreased glutamate transporter activity and thus, a 
buildup of extracellular glutamate (for a review, see Arundine & Tymianski, 2004; 
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Camacho & Massieu, 2006).  As discussed earlier, the accumulation of glutamate can 
lead to excessive activation of glutamate receptors, in particular the NMDA receptor, 
which is highly permeable to Ca2+.  Early studies revealed that cell death due to ischemic 
injuries was preventable by the addition of Mg2+ (Kass & Lipton, 1982; Rothman, 1983).  
It was later found that ischemia-induced cell death was mediated by the release of EAAs, 
which the author suggested was most likely glutamate or aspartate (Rothman, 1984).  
Indeed, the NMDA receptor has been repeatedly implicated in hypoxic/ischemic injury 
(Meldrum, Evans, Swan, & Simon, 1987; Simon, et al., 1984).  Recent studies have 
shown that disrupting the NMDA receptor-PSD 95 interaction may be a useful treatment 
for ischemia-related injuries (Aarts, et al., 2002).  Furthermore, calpain inhibitors and the 
removal of Ca2+ have been shown effective in reducing ischemia-induced cell death 
(Brana, Benham, & Sundstrom, 1999; Underhill & Goldberg, 2007). 
 
Ca2+-mediated Excitotoxicity in Traumatic Brain Injury 
 Calcium-induced excitotoxicity has also been shown to be involved in the effects 
elicited after a traumatic brain injury (TBI).  Cell death can occur as a direct result of the 
central nervous system (CNS) tissue perturbation (primary injury) or as a result of the 
mechanisms triggered by the surviving cells (secondary injury), leading to further 
damage or death (for a review, see Arundine, et al., 2003).  Recently, this theory was 
affirmed by studies which found that hippocampal neurons surviving the initial insult had 
increased intracellular Ca2+ levels as well as long-lasting abnormalities in mechanisms 
maintaining Ca2+ homeostasis (Sun, et al., 2008).  Moreover, administration of the 
calpain inhibitor MDL28170 has been shown to improve both the locomotor function as 
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well as the pathological outcome following a spinal cord injury, suggesting that 
excitotoxic injury to the CNS may be in part mediated by Ca2+-dependent pathways (Yu, 
Joshi, & Geddes, 2008). 
 
Ca2+-mediated Excitotoxicity in Alcohol Abuse & Withdrawal 
Acutely, alcohol inhibits the excitatory glutamate NMDA receptors while 
facilitating the actions of chloride at the inhibitory γ-amino butyric acid (GABA) receptor 
(see Nagy, 2008 for a review).  Conversely, chronic alcohol can lead to a compensatory 
upregulation of NMDA receptors.  In particular, chronic ethanol resulted in an 
upregulation of the NMDA receptor subunits NR1, NR2A, and NR2B following a 
western blot analysis (Kalluri, Mehta, & Ticku, 1998).  This increase in NMDA receptors 
attempts to counteract the effect of acute alcohol; however, the increase in NMDA 
receptors and subsequent overactivation during ethanol withdrawal is also thought to 
mediate the damaging effects associated with alcohol withdrawal (Allgaier, 2002).  
Rodent models investigating ethanol withdrawal lend support for the NMDA receptor 
hyperexcitability theory, as ethanol-dependent rats given NMDA while in the midst of 
ethanol withdrawal were more prone to handling-induced seizures; however, 
administration of the NMDA receptor antagonist MK-801 to ethanol-dependent rats 
during withdrawal  resulted in decreased frequency and severity of handling-induced 
seizures (Grant, Valverius, Hudspith, & Tabakoff, 1990).  Furthermore, NMDA receptor 
antagonists have been shown to block the toxicity and Ca2+ influx associated with ethanol 
withdrawal (Mayer, et al., 2002b).   
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Ca2+-mediated Excitotoxicity: Role of the NMDA Receptor 
Seemingly, since the NMDA receptor is more permeable to Ca2+ than the AMPA 
or kainate receptor and Ca2+ is thought to be a key mediator of excitotoxicity, it has been 
the focus of much research over the past two decades.  An earlier study found that the 
addition of the competitive NMDA receptor antagonist APV dose dependently blocked 
NMDA-induced excitotoxicity and reduced glutamate-induced excitotoxicity (Choi, Koh, 
& Peters, 1988).  In the same study, it was found that other NMDA receptor antagonists 
reduced glutamate mediated excitotoxicity while AMPA or kainate receptor antagonists 
did not, suggesting that glutamate-induced excitotoxicity is likely mediated, at least in 
part, by NMDA receptors (Choi, et al., 1988).   
The NMDA receptor has also been implicated in the Ca2+-dependent pathways 
leading to necrosis and/or apoptosis.  Early studies revealed that NMDA receptor 
activation leads to the activation of a neuronal protein phosphatase, presumably the Ca2+-
dependent phosphatase calcineurin, to dephosphorylate the protein dopamine and cyclic 
AMP –regulated phosphoprotein-32 (DARPP-32), an effect blocked by the addition of 
the competitive NMDA antagonist APV (Halpain, Girault, & Greengard, 1990).  Another 
study found that stimulation of the NMDA receptor leads to activation of the Ca2+-
dependent protease calpain (Gellerman, Bi, & Baudry, 1997).  One recent study found 
that both NMDA and non-NMDA glutamate receptor agonism activated calpain; 
however, only the NMDA antagonist was effective at reducing glutamate-induced 
toxicity (Del Rio, Montiel, & Massieu, 2008).   
Brief NMDA exposure has also been shown to have effects on the dendrites of the 
neuron.  More specifically, brief exposure to NMDA (as little as five minute exposure at 
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50 µM concentration) resulted in a loss of dendritic spines and filamentous actin staining 
at synapses (Halpain, Hipolito, & Saffer, 1998).  The effect of NMDA on actin was 
significantly attenuated by pretreatment with an actin stabilizer or by a calcineurin 
inhibitor, ascomycin, suggesting that calcineurin inhibitors could be useful in attenuating 
glutamate-mediated effects on actin stability (Halpain, et al., 1998).  Similarly, a brief 
NMDA exposure (30 µM for 10 minutes) resulted in dendritic swelling first evident in 
the most distal branches and later evident in the more proximal branches (Hoskison, 
Yanagawa, Obata, & Shuttleworth, 2007).  The same study found that immunoreactivity 
for the microtubule-associated protein MAP2 was also lost progressively from the distal 
dendritic branches and that this loss in MAP2, as well as the damage seen in the 
dendrites, was Ca2+ dependent (Hoskison, et al., 2007).   
 
Experimental Rationale 
 These studies examined the time-dependent loss of the synaptic vesicular protein 
synaptophysin and the loss of NMDA receptor NR1 subunit availability following an 
excitotoxic insult to provide a better understanding of the topographical nature of 
neuronal death following NMDA receptor activation.  Thus, immunoreactivity of a 
synaptic vesicle protein (synaptophysin) present mainly in axons, a cell death/damage 
marker (propidium iodide) which binds nucleic acids within the cell body, and an 
antibody against the NMDA NR1 subunit present mainly on dendrites were used to 
assess the time-dependent cellular breakdown of NMDA-induced excitotoxicity.  The 
topographical "mapping" of cellular injury or death following EAA receptor activation is 
important because previous studies indicate the cell may not die all at once (Hoskison, et 
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al., 2007) but that neuronal death may be dependent on the part of the neuron that is 
injured and the amount of time following the insult.  For example, previous research has 
indicated that the dendrites may be sensitive to rapid glutamate-induced excitotoxicity 
(Hoskison, et al., 2007).  Thus, if the manner in which the neuron breaks down can be 
elucidated, novel therapeutics can target that particular part of the neuron first.   
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Chapter Two 
Methods 
Organotypic Hippocampal Cell Culture  
Eight day old male and female Spraque-Dawley rats (acquired from Harlan 
Laboratories; Indianapolis, IN) were humanely sacrificed and the brains aseptically 
removed.  Following removal, brains were transferred to ice-cold dissecting media, 
composed of Minimum Essential Medium (MEM; Invitrogen, Carlsbad, CA), 25 mM 
HEPES (Sigma, St. Louis, MO), and 50 µM streptomycin/penicillin (Invitrogen).  
Bilateral hippocampi were removed in whole and cleaned of extra tissue under a 
dissecting microscope.  Hippocampi were then placed into culture media, which contains 
dissecting medium along with distilled water, 36 mM glucose (Fisher, Pittsburg, PA), 
25% Hanks’ Balanced Salt Solution (HBSS; Invitrogen), 25% (v/v) heat-inactivated 
horse serum (HIHS; Sigma), and 0.05% streptomycin/penicillin (Invitrogen).  Unilateral 
hippocampi were sectioned at 200 µm using a McIllwain Tissue Chopper (Mickle 
Laboratory Engineering Co. Ltd., Gomshall, UK).  Following sectioning, three intact 
hippocampal slices were plated onto Millicell-CM 0.4 µm biopore membrane inserts with 
1 mL of pre-incubated culture media added to the bottom of each well of a six well plate, 
yielding a total of 18 intact slices per plate.  Excess culture medium was aspirated off of 
the top of each well and the plates were then incubated at 37°C with a gas composition of 
5% CO2/95% air for 5 days to allow tissue to affix to the Teflon membrane.  Care of all 
animals was carried out in agreement with the University of Kentucky’s Institutional 
Animal Care and Use Committee.  
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Drug Exposure 
 At 5 days in vitro, slices were randomly transferred to new culture plates 
containing either 1 mL of culture media or either NMDA (20 µM; Sigma), APV (50 µM; 
Sigma) or NDMA + APV (same concentrations as above) dissolved in 1 mL of culture 
media.  The concentration of NMDA chosen has been shown to be effective in producing 
cytotoxicity in previous studies (Mulholland & Prendergast, 2003).  The concentration of 
APV was chosen based on preliminary data indicating that 20 µM was not able to 
significantly overcome the neurotoxic effects of 20 µM NMDA (not shown).  Propidium 
Iodide (PI; 3.74 µM; Molecular Probes Eugene, OR) was also added to each well.  PI is a 
nucleic stain used to detect cell damage and was used to measure cytotoxicity as 
described below.   
 At 24, 72, and 120 hours following the initial NMDA and PI exposure, tissue 
slices were imaged for cytotoxicity and subsequently fixed to assess NMDA NR1 subunit 
and synaptophysin immunoreactivity by transferring the hippocampal slice insert to a 
plate containing 1 mL of 10% formalin solution on the bottom of each well.  One mL of 
formalin was also placed on top of the insert and the plates were allowed to sit for 30 
minutes.  The slices were then washed carefully (1 mL on bottom of the well and 1 mL 
on top of the well) with 1% phosphate buffered saline (PBS) twice and stored with 1 mL 
of 1% PBS on the bottom of the well overnight at 4°C.  All experiments were replicated 
at least twice, with each experimental condition (treatment by exposure time by sex 
within region) containing 18-27 slices.   
In a final series of experiments, slices (5 DIV) were exposed to either NMDA 
alone (20 μM) or control conditions to investigate the rapid timecourse of NMDA-
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induced cytotoxicity.  This experiment was conducted to determine if less than 24 hours 
of exposure to NMDA produced changes in cytotoxicity or synaptophysin 
immunoreactivity.  At 15 or 120 minutes following the initial NMDA and PI exposure, 
slices were imaged for cytotoxicity and immediately fixed as described above for 
synaptophysin immunohistochemistry.  This experiment was replicated twice, yielding a 
total of 18 slices per experimental condition (treatment by exposure time by sex within 
region).    
 
Cytotoxicity assessment 
 Cytotoxicity (propidium iodide staining of neurons and glia with damaged 
membranes) was measured in the granule cells of the dentate gyrus (DG), the pyramidal 
cell layer of the cornu ammonis 3 (CA3) and the pyramidal cell layer of the cornu 
ammonis 1 (CA1) regions of the hippocampal formation using fluorescent microscopy.  It 
has been shown previously that PI reliably correlates with other measures of cell death 
(for a review, see Zimmer, Kristensen, Jakobsen, & Noraberg, 2000).  Slices were 
visualized with SPOT advanced version 4.0.2 software for Windows (W. Nuhsbahm Inc.; 
McHenry, IL, USA) using a 5x objective with a Leica DMIRB microscope (w. 
Nuhsbahm Inc.; McHenry, IL, USA) fitted for fluorescence detection (mercury-arc lamp) 
and connected to a personal computer  through a SPOT 7.2 color mosaic camera (W. 
Nuhsburg).   PI has an emission wavelength of 620 nm in the visual range and a peak 
excitation wavelength of 536 nm and was excited using a band-pass filter which emits a 
range of wavelengths (510-560 nm).  Densitometry using Image J software (National 
Institutes of Health, Bethesda, MD) was used to measure the intensity of the PI 
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fluorescence.  A background measurement was taken from the visual field surrounding 
each slice and was subsequently subtracted from the regional measurements of each slice.  
The fluorescent intensity was measured in each of the three regions of interest: the 
granule cell layer of the dentate gyrus and the pyramidal cell layers of the CA3 and CA1 
regions of the hippocampus.  Within each region, measurements of PI uptake were 
converted to percent control to limit potential differences between replications across 
weeks.   
 
Immunohistochemistry 
Following overnight storage, the inserts were transferred to a plate containing 1 
mL of permeabilization buffer (200 mL 1% PBS [Invitrogen], 200 µL Triton X-100 
[Sigma], 0.010 mg Bovine Serum [Sigma]) in each well and 1 mL of PBS buffer was also 
placed on top of each insert containing the slices.  The slices were allowed to sit in buffer 
for 45 minutes to allow the buffer to penetrate the slice and were then washed twice with 
1% PBS as described earlier.  Inserts were then transferred to a plate containing 1 mL of 
1% PBS on the bottom of each well and were treated with 1 mL of buffer containing 
either mouse anti-NR1 (1:100; BD Biosciences PharMingen, San Jose, CA) or mouse 
anti-synaptophysin (1:200; Sigma) on top of each well.  Plates were then stored at 4°C 
for 24 hours.  Following 24 hours, the slices were washed gently with 1% PBS twice and 
were again transferred to a plate containing 1 mL of 1% PBS on bottom.  At this point, 
slices were treated with 1 mL of buffer containing the goat anti-mouse secondary 
antibody conjugated to fluorescein isothiocyanate (FITC; 1:100; Sigma) on top of the 
insert and were stored at 4°C for 24 hours.  After 24 hours, slices were washed twice with 
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1% PBS as described previously and placed into a plate containing 1 mL of 1% PBS on 
the bottom of each well.  The slices were then imaged immediately.  A range of 
concentrations was previously tested and the concentrations of NR1, synaptophysin, and 
FITC antibodies chosen were shown to have the least amount of background signal while 
maintaining a strong, specific signal within the regions of interest.   
 
NMDA NR1 subunit density assessment 
 To assess the effects of NMDA-induced excitotoxicity on NR1 subunit 
expression, immunoreactivity was measured in the dentate gyrus, CA1 and CA3 regions 
of the hippocampus using FITC fluorescence.  The slices were visualized as described 
previously above.  The secondary antibody with FITC was excited using a band-pass 
filter at 495 nm (520 nm emission).  Densitometry using Image J software (National 
Institutes of Health, Bethesda, MD) was used to measure the intensity of the FITC 
fluorescence.  A background measurement of fluorescence was taken from the visual 
field surrounding each slice and was subsequently subtracted from the region 
measurements of each slice before analysis.  The intensity was again measured in each of 
the three regions of interest: the granule cell layer of the dentate gyrus and the pyramidal 
cell layers of the CA3 and CA1 regions of the hippocampus.  To minimize the variability 
between each replication, measurements of FITC immunoreactivity were converted to 
percent control for each region.   
 
Synaptophysin assessment 
21 
 
  To assess the effects of NMDA-induced cytotoxicity on the synaptic vesicular 
protein synaptophysin, measurement of synaptophysin in the dentate gyrus, CA1 and 
CA3 regions of the hippocampus were visualized using fluorescent microscopy. The 
slices were again visualized as described previously.  The secondary antibody conjugated 
to FITC was excited using a band-pass filter at 495 nm (520 nm emission).  Densitometry 
using Image J software (National Institutes of Health, Bethesda, MD) was again used to 
measure the intensity of the FITC fluorescence.  A background measurement of 
fluorescence was taken from the visual field surrounding each slice and was subsequently 
subtracted from the region measurements of each slice before analysis.  The intensity was 
measured in each of the three regions of interest: the granule cell layer of the dentate 
gyrus and the pyramidal cell layers of the CA3 and CA1 regions of the hippocampus.  
Within each region, measurements of FITC immunoreactivity were converted to percent 
control prior to analysis.  
 
Statistical analyses 
Each experiment was conducted a minimum of 2 times using different rat litters. 
Data from each replication were converted into percent control values and were 
subsequently combined since litter effects were absent, yielding 18-27 slices per 
condition (treatment by exposure time by sex within each region).  Previous studies have 
shown a differential vulnerability between the regions of the hippocampus, with the CA1 
region being the most vulnerable to excitotoxic insult (Butler, et al., 2010).  Thus, a two-
way analysis of variance test (ANOVA) was conducted (region x exposure time) on the 
raw control values for differences in regions across time for each measurement (PI, NR1 
22 
 
immunoreactivity, and synaptophysin immunoreactivity).  For experiments examining the 
effects of NMDA and APV, a three-way ANOVA was conducted (treatment x exposure 
time x sex) for each region of the hippocampus (DG, CA1, CA3).  The levels of 
treatment were NMDA alone, APV alone, or NDMA+APV exposure.  The levels of time 
were 24, 72, and 120 hours following initial NMDA exposure.  Thus, treatment groups 
were compared to the time-appropriate control condition.   For experiments investigating 
the rapid timecourse of NMDA-induced toxicity (without APV), a three-way ANOVA 
was conducted (treatment x exposure time x sex) for each region of the hippocampus 
(DG, CA1, CA3).  For this experiment, the levels of time were 15 and 120 minutes; the 
treatment (NMDA alone) groups were compared to the time-appropriate control 
condition.  Outliers were identified using Grubbs’ test for outliers and were subsequently 
removed from all further analyses.  When appropriate, post-hoc tests were conducted 
using Fisher’s LSD to examine further effects.  Statistical significance was set at p<0.05.   
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Chapter Three 
Results 
Raw control values 
 The raw values from control-treated cultures were examined for regional 
differences in all markers across time.  PI fluorescence is measured in arbitrary optical 
units, reflecting pixel intensity in the defined region.  With regard to control levels of PI 
uptake, main effects for both region (CA1/CA3/DG; F(2, 315)=56.464, p<0.001) and 
time (24/72/120 hour exposure; F(2, 315)=15.264, p<0.001) were found.  A significant 
interaction between region and time was also found (Figure 3.1A; F(4, 315)=17.571, 
p<0.001).  Within the CA1, PI uptake following 120 hour exposure was significantly 
more from that seen following either 72 hour exposure (21.426 vs. 16.789 arbitrary units, 
respectively; Fisher’s LSD post-hoc, p < 0.05) or 24 hour exposure (13.915; Fisher’s 
LSD post-hoc, p < 0.05).  The arbitrary level of PI uptake in the CA1 following 72 hour 
exposure was also significantly more than that following 24 hour exposure (Fisher’s LSD 
post-hoc, p < 0.05).  In contrast, within the CA3, PI uptake in cultures exposed to control 
treatment for 120 hour was significantly less than that seen following 24 hour exposure 
(18.072 vs. 21.454 arbitrary units, respectively; Fisher’s LSD post-hoc, p < 0.05).  The 
arbitrary units of PI uptake in the DG region following 120 hour exposure was 
significantly greater than that seen following either 72 hour exposure (16.508 vs. 13.723, 
respectively; Fisher’s LSD post-hoc, p < 0.05) or 24 hour exposure (11.432; Fisher’s 
LSD post-hoc, p < 0.05).  Further, the control raw level of PI uptake in the DG following 
72 hour exposure was significantly greater as compared to 24 hour exposure (Fisher’s 
LSD post-hoc, p < 0.05).   
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In regard to region within time, in the 120 hour exposed group, the CA1 was 
found to have the greatest raw value of PI uptake as compared to either the CA3 (Figure 
3.1A; 21.426 vs. 18.072 arbitrary units, respectively; Fisher’s LSD post-hoc, p < 0.05) or 
the DG (16.508; Fisher’s LSD post-hoc, p < 0.05).  Conversely, following 72 hour 
exposure, the CA3 region of the hippocampus had the greatest arbitrary level of PI uptake 
as compared to either the CA1 (19.886 vs. 16.789, respectively; Fisher’s LSD post-hoc, p 
< 0.05) or the DG region (13.723; Fisher’s LSD post-hoc, p < 0.05).  Also following 72 
hour exposure time, the CA1 had significantly greater raw levels of PI uptake compared 
to the DG region (Fisher’s LSD post-hoc, p < 0.05).  Similarly, at the 24 hour timepoint, 
the CA3 region had the greatest level of raw PI uptake as compared to either the CA1 
(21.454 vs. 13.915, respectively; Fisher’s LSD post-hoc, p < 0.05) or the DG (11.432; 
Fisher’s LSD post-hoc, p < 0.05) regions of the hippocampus and the CA1 also had a 
significantly greater level of raw PI uptake as compared to the DG region (Fisher’s LSD 
post-hoc, p < 0.05).   
 The raw control values of NR1 immunoreactivity were also examined for 
differences among regions across the timepoints.  The two-way (region by exposure time) 
ANOVA revealed a main effect of region, F(2, 315)=176.967, p<0.001 as well as a 
significant interaction between region and exposure time, (Figure 3.1B; F(4, 315)=4.541, 
p<0.001).  Further analysis of the interaction revealed that within the CA3 region, raw 
NR1 immunoreactivity levels were significantly lower following 120 exposure than 
either 72 hour exposure (11.139 vs. 13.467 arbitrary units, respectively; Fisher’s LSD 
post-hoc, p < 0.05) or 24 hour exposure (13.943; Fisher’s LSD post-hoc, p < 0.05).  
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There were no significant differences in NR1 immunoreactivity among timepoints within 
the CA1 or the DG.   
Within each timepoint, the CA1 region consistently had greater raw levels of NR1 
immunoreactivity as compared to either the CA3 (Fisher’s LSD post-hoc, p < 0.05) or 
DG regions of the hippocampus.  Further, following either 24 or 72 hour exposure, raw 
NR1 immunoreactivity levels in the CA3 were significantly higher (13.943 and 13.467, 
respectively) than that seen in the DG from the same timepoints (12.548 and 12.099, 
respectively; Fisher’s LSD post-hoc, p < 0.05).  Conversely, following 120 hour 
exposure, the DG had greater levels of raw NR1 immunoreactivity as compared to the 
CA3 within the same exposure time (12.506 vs. 11.139, respectively; Fisher’s LSD post-
hoc, p < 0.05).   
 The raw control values of synaptophysin immunoreactivity were also examined 
for differences among regions across time.  The two-way ANOVA revealed significant 
main effects of both region (F(2, 315)=185.558, p<0.001) and exposure time (F(2, 
315)=49.244, p<0.001).  A significant interaction between region and exposure time was 
also revealed (Figure 3.1C; F(4, 315)=10.161, p<0.001).  Within each region of the 
hippocampus, the raw value of synaptophysin immunoreactivity following 120 hour 
exposure was significantly greater than that seen following either 72 hour exposure 
(Fisher’s LSD post-hoc, p < 0.05) or 24 hour exposure (Fisher’s LSD post-hoc, p < 0.05).  
Further, within the CA1 region only, the raw value of synaptophysin immunoreactivity 
following 72 hour exposure was significantly greater than that seen following 24 hour 
exposure (26.727 vs. 20.128, respectively; Fisher’s LSD post-hoc, p < 0.05).   
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Within each timepoint, the CA1 region of the hippocampus had significantly 
greater values of raw synaptophysin immunoreactivity compared to either the CA3 
(Figure 3.1C; Fisher’s LSD post-hoc, p < 0.05) or DG (Fisher’s LSD post-hoc, p < 0.05) 
regions.  There were no significant region differences between the CA3 and DG at any of 
the timepoints examined.    
 
NMDA-induced cytotoxicity 
 Studies were conducted to assess the effect of the glutamate NMDA receptor 
agonist NMDA alone, the NMDA competitive antagonist APV alone, and NMDA with 
APV at various timepoints (24, 72, and 120 hours) on PI uptake, a measure of cell death 
or damage.  As there was no difference in PI uptake between sexes within each treatment 
group, data was collapsed over the sex variable.  Thus, a two-way (treatment by exposure 
time) within each region was conducted.  Within the CA1 region of the hippocampus, 
significant main effects were found for both treatment 
(CTRL/NMDA/APV/NMDA+APV; F(3, 420)=399.33, p<0.001) and time (24/72/120 
hour exposure; F(2, 420)=35.586, p<0.001).  Interestingly, a significant interaction 
between treatment and time was also observed (Figure 3.2; F(6, 420=30.842, p<0.001).  
Thus, within each timepoint, NMDA exposure resulted in a significant increase in PI 
uptake compared to control and APV treated tissue, and the addition of the competitive 
NMDA antagonist APV significantly attenuated this increase (Fisher’s LSD post-hoc, p < 
0.05).  Co-exposure of NMDA and APV for 24 or 72 hours resulted in a small (~130% 
control), but significant, increase in PI uptake compared to control- and APV-treated 
cultures (Fisher’s LSD post-hoc, p < 0.05); however, this effect was not seen following 
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120 hour exposure.  Hence, the addition of APV significantly decreased NMDA-induced 
toxicity, though not to control levels before 120 hours of exposure.   
When looking at the effects of time within treatment groups, the effect of NMDA 
exposure on PI uptake within the CA1 was time dependent, such that the most robust 
NMDA-induced PI uptake was seen at the 24 hour timepoint (~375% control) while a 
smaller, yet still significant, increase in PI uptake was seen at the 72 and 120 hour 
timepoints (~290% and 198 % control, respectively; Fisher’s LSD post-hoc, p < 0.05). 
Thus, PI uptake following NMDA exposure for 72 and 120 hours was significantly 
different from that seen following 24 hour NMDA exposure (Figure 3.2; Fisher’s LSD 
post-hoc, p < 0.05).  Similarly, PI uptake after 120 hour NMDA exposure was 
significantly different from that seen at the 72 hour timepoint (Fisher’s LSD post-hoc, p < 
0.05).   
A significant main effect of treatment (F(3, 420=14.80, p<0.001) and time (F(2, 
420=3.173, p<0.05) was observed in the CA3 while no significant interaction was found 
(Figure 3.2).  Collapsed across time, significant increases in PI uptake were found in 
cultures exposed to NMDA or co-exposed to NMDA+APV (~115% control) compared to 
control and APV alone treated cultures (Fisher’s LSD post-hoc, p < 0.05).  Further, data 
collapsed across treatment groups revealed a significant difference among timepoints, 
such that PI uptake following either 24 or 72 hour exposure was significantly greater than 
PI uptake following 120 hour exposure (110% control and 109% control vs. 102% 
control, respectively; Fisher’s LSD post-hoc, p < 0.05).  
Within the DG, a significant main effect of treatment was found (F(3, 
420)=23.367, p<0.001); however, no significant main effect of time or significant 
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interaction between time and  treatment was observed (Figure 3.2).  Collapsed across 
time, both NMDA and NMDA+APV treated cultures resulted in a significant increase 
(~120% control) in PI uptake as compared to control and APV alone treated cultures 
(Fisher’s LSD post-hoc, p < 0.05); the effect of NMDA was also significantly attenuated 
by co-exposure with APV (~125% control vs. ~116% control, respectively; Fisher’s LSD 
post-hoc, p < 0.05).  Representative images of these effects are presented in Figure 3.3. 
 
NMDA-induced loss of NR1 Subunit Immunoreactivity 
 Further studies were conducted to assess the effects of NMDA, APV, and 
NMDA+APV exposure on the NMDA receptor subunit 1 immunoreactivity.  As with the 
PI measurement, sex differences were not observed measuring NR1 subunit expression 
and the data were combined.  Within the CA1 region of the hippocampus, a significant 
main effect of treatment was found (F(3, 420)=20.286, p<0.001).  Also in the CA1, there 
was no significant main effect of time; however, a significant interaction of treatment and 
time was observed (Figure 3.4; F(6, 420)=4.392, p<0.001).  In regard to the interaction of 
treatment within time, exposure to NMDA caused a time-dependent decrease in NR1 
immunoreactivity in the CA1 region such that 24 hour exposure to NMDA resulted in no 
significant change in NR1 immunoreactivity compared to control- or APV-treated 
cultures, while 72 and 120 hour exposure to NMDA resulted in a significant decrease 
(88% control and 80% control, respectively) below that seen in control- or APV-treated 
cultures (Fisher’s LSD post-hoc, p < 0.05).  This effect of NMDA in the CA1 was 
blocked by the co-exposure of NMDA with APV, as NR1 immunoreactivity levels of 
NMDA+APV treated cultures at 72 and 120 hour timepoints were significantly higher 
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(109% control and 107% control, respectively) than NR1 immunoreactivity levels seen in 
NMDA  treated cultures (88% control and 80% control, respectively; Fisher’s LSD post-
hoc, p < 0.05).  At the 72 hour timepoint, APV co-exposure prevented NMDA-induced 
decreases in NR1 immunoreactivity to levels above control-treated cultures (107% 
control for APV-treated cultures; Fisher’s LSD post-hoc, p < 0.05).  At the 120 hour 
timepoint, exposure to APV alone resulted in a significant increase in NR1 
immunoreactivity in the CA1 region as compared to control cultures (109% control; 
Fisher’s LSD post-hoc, p < 0.05).   
Further, in regard to the factor of time within treatment groups, NR1 subunit 
immunoreactivity in the CA1 following NMDA exposure for 72 and 120 hours was 
significantly less than that seen following 24 hour NMDA exposure (88% control and 
80% control vs. 98% control, respectively; Fisher’s LSD post-hoc, p < 0.05).  In fact, 
following 120 hour exposure to NMDA alone, a significant decrease in NR1 
immunoreactivity in the CA1 was found as compared to 72 hour exposure to NMDA 
alone (Fisher’s LSD post-hoc, p < 0.05).  Thus, each timepoint was significantly different 
than the others when treated with NMDA alone. 
As seen with the PI data, no significant interaction was discovered within the CA3 
region; however, a significant main effect of time on NR1 immunoreactivity within the 
CA3 was observed (Figure 3.4; F(2, 420)=4.084, p<0.05).  Collapsed across treatment, 
cultures exposed for 24 or 72 hours resulted in significant decreases in NR1 
immunoreactivity in the CA3 as compared to cultures exposed for 120 hours.   
No significant main effects of treatment or exposure time were observed in the 
DG region of the hippocampus (Figure 3.4).  Results also showed no significant 
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interaction between treatment and time within the DG.  Representative images of 
hippocampal slices are shown in Figure 3.5. 
 
NMDA-induced loss of Synaptophysin 
Additional studies were conducted to assess the effects of NMDA, APV, and 
NMDA+APV exposure on the immunoreactivity of the synaptic vesicle protein, 
synaptophysin.  A three-way ANOVA (treatment x exposure time x sex) was initially 
conducted, but as no sex differences were observed, the data were later combined for 
simplicity.  Thus, a two-way ANOVA (treatment x exposure time) within each region 
was conducted.  Within the CA1, a significant main effect of treatment was found (F(3, 
420)=75.442, p<0.001).  While no significant main effect of time within the CA1 was 
observed, a significant interaction of treatment by time in the CA1 was uncovered (Figure 
3.6; F(6, 420)=5.347, p<0.001).  Within each timepoint examined, NMDA exposure 
resulted in a time-dependent decrease in synaptophysin immunoreactivity and the 
addition of APV blocked this NMDA-induced effect, such that exposure to NMDA+APV 
resulted in synaptophysin immunoreactivity levels at or above those seen with control 
slices (Fisher’s LSD post-hoc, p < 0.05).   
In regard to the effect of time within treatment groups, the NMDA-induced 
decrease in synaptophysin immunoreactivity within the CA1 was shown to be time-
dependent such that longer exposure (i.e. 72 or 120 hour) produced a significantly greater 
deficit (42% control and 32% control, respectively) in synaptophysin immunoreactivity 
compared to shorter exposure (i.e. 24 hour; 72% control); however, the NMDA-induced 
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loss of synaptophysin immunoreactivity was significantly different from control or APV 
treated cultures at all exposure times measured (Fisher’s LSD post-hoc, p < 0.05).   
 While significant main effects of both time (F(3,420)=5.681, p<0.001) and 
treatment (F(2, 420)=7.396, p<0.001) were found within the CA3, no significant 
interaction was observed (Figure 3.6).  Collapsed across time, treatment with NMDA 
resulted in a significant decrease (84% control) in synaptophysin immunoreactivity in the 
CA3 as compared to control or APV treated cultures (Fisher’s LSD post-hoc, p < 0.05).  
The loss of synaptophysin immunoreactivity in the CA3 following NMDA exposure was 
significantly attenuated by co-exposure of NMDA and APV (Fisher’s LSD post-hoc, p < 
0.05).  Further, data collapsed across treatment revealed that cultures exposed for 24 or 
72 hours had significantly higher synaptophysin immunoreactivity levels (both ~98% 
control) from cultures treated 120 hours (86% control; Fisher’s LSD post-hoc, p < 0.05).   
A significant main effect of treatment (F(3,420)=16.169, p<0.001) was observed 
within the DG; however, no further significant effects were discovered (Figure 3.6).  
Collapsed across time, treatment with NMDA resulted in a significant decrease (73% 
control) in synaptophysin immunoreactivity in the DG region of the hippocampus as 
compared to control or APV treated cultures (Fisher’s LSD post-hoc, p < 0.05).  The loss 
of synaptophysin immunoreactivity in the DG following NMDA exposure was 
significantly attenuated by co-exposure of NMDA and APV (Fisher’s LSD post-hoc, p < 
0.05).  Representative images of hippocampal slices labeled with synaptophysin are 
shown in Figure 3.7.   
 
Rapid timecourse of NMDA-induced toxicity 
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 Subsequent studies were conducted to determine if NMDA (20 μM) produced 
rapid changes in either cytotoxicity as measured by PI uptake or synaptophysin 
immunoreactivity prior to 24 hours (at 15 or 120 minutes following initial exposure) as 
compared to control conditions.  Thus, a three-way ANOVA (treatment x exposure time 
x sex) was initially conducted, but as no sex differences were observed, the data were 
later combined for simplicity.  A two-way ANOVA (treatment x exposure time) within 
each region was then conducted.  Regarding PI uptake within the CA1 region, a 
significant main effect of treatment was observed (Figure 3.8; F(1, 136)=39.183, 
p<0.001), such that exposure to NMDA resulted in an increase in PI uptake (~272% 
control); however, there no further significant main effects or interactions within the 
CA1.  Similarly, there were no significant main effects or interactions in the CA3 or DG 
when examining the effects of NMDA on rapid PI uptake (Figure 3.8).   
 The rapid effects of NMDA seen prior to 24 hours were also investigated by 
examining differences in synaptophysin immmunoreactivity.  As with the rapid changes 
in PI uptake, no sex differences were observed with synaptophysin immunoreactivity.  
No significant main effects of interactions of treatment and exposure time were observed 
in any of the regions examined (Figure 3.9).   
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Figure 3.1.  Effects of region and exposure time on the raw control values for PI uptake 
(A), NR1 immunoreactivity (B), and synaptophysin immunoreactivity (C).  * = p<0.05 
vs. 24 hour within region; ** = p<0.05 vs. 72 hour within region; # = p<0.05 vs. CA1 
region within time; + = p<0.05 vs. CA3 region within time 
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Figure 3.2. Effects of exposure to the glutamate NMDA receptor agonist NMDA, the 
competitive antagonist APV, or NMDA+APV on toxicity observed in the organotypic 
hippocampal slice cultures.  Exposure to NMDA resulted in significant time-dependent 
toxicity within the CA1 region of the hippocampus, an effect which was prevented by co-
exposure to APV.   * = p<0.05 vs. control levels; # = p<0.05 vs. NMDA alone   
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Figure 3.3. Representative images of the effects of exposure to the glutamate NMDA 
receptor agonist NMDA, the competitive antagonist APV, or NMDA+APV on toxicity 
observed in the organotypic hippocampal slice cultures. A. 24 HR control; B. 24 HR 
APV alone; C. 24 HR NMDA alone; D. 24 HR NMDA+APV; E. 72 HR control; F. 72 
HR APV alone; G. 72 HR NMDA alone; H. 72 HR NMDA+APV; I. 120 HR control;  
J. 120 HR APV alone; K. 120 HR NMDA alone; L. 120 HR NMDA+APV 
 
   
 
B  C A  D 
F  G E  H 
 
J  K  L I 
 
 
 
 
 
 
 
 
 
 
 
 
36 
 
Figure 3.4. Effects of exposure to the glutamate NMDA receptor agonist NMDA, the 
competitive antagonist APV, or NMDA+APV on NR1 subunit immunoreactivity 
observed in the organotypic hippocampal slice cultures.  Exposure to NMDA resulted in 
significant time-dependent NR1 loss within the CA1 region of the hippocampus, an effect 
which was prevented by co-exposure to APV.  * = p<0.05 vs. control levels; # = p<0.05 
vs. NMDA alone     
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Figure 3.5. Representative images of the effects of exposure to the glutamate NMDA 
receptor agonist NMDA, the competitive antagonist APV, or NMDA+APV on NR1 
subunit immunoreactivity observed in the organotypic hippocampal slice cultures. A. 24 
HR control; B. 24 HR APV alone; C. 24 HR NMDA alone; D. 24 HR NMDA+APV; E. 
72 HR control; F. 72 HR APV alone; G. 72 HR NMDA alone; H. 72 HR NMDA+APV; 
I. 120 HR control; J. 120 HR APV alone; K. 120 HR NMDA alone; L. 120 HR 
NMDA+APV 
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Figure 3.6. Effects of exposure to the glutamate NMDA receptor agonist NMDA, the 
competitive antagonist APV, or NMDA+APV on the synaptic vesicle protein 
synaptophysin immunoreactivity observed in the organotypic hippocampal slice cultures.  
Exposure to NMDA resulted in significant time-dependent synaptophysin loss within the 
CA1 region of the hippocampus, an effect which was prevented by co-exposure to APV.    
* = p<0.05 vs. control levels; # = p<0.05 vs. NMDA alone   
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Figure 3.7. Representative images of the effects of exposure to the glutamate NMDA 
receptor agonist NMDA, the competitive antagonist APV, or NMDA+APV on 
synaptophysin immunoreactivity observed in the organotypic hippocampal slice cultures. 
A. 24 HR control; B. 24 HR APV alone; C. 24 HR NMDA alone; D. 24 HR 
NMDA+APV; E. 72 HR control; F. 72 HR APV alone; G. 72 HR NMDA alone; H. 72 
HR NMDA+APV; I. 120 HR control; J. 120 HR APV alone; K. 120 HR NMDA alone; 
L. 120 HR NMDA+APV; M. control image labeling the regions of the hippocampus 
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Figure 3.8. Effects of exposure to the glutamate NMDA receptor agonist NMDA on rapid 
changes in cytotoxicity as measured by PI uptake prior to 24 hours (at 15 and 120 
minutes).  Exposure to NMDA produced significant toxicity in the CA1 region when 
collapsed over time. * = p<0.05 vs. control levels. 
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Figure 3.9. Rapid effects of exposure to the glutamate NMDA receptor agonist NMDA 
on synaptophysin immunoreactivity as measured prior to 24 hours (at 15 and 120 
minutes).  Exposure to NMDA for 15 or 120 minutes did not produce significant changes 
in synaptophysin levels. 
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Chapter Four 
Discussion 
Excitotoxicity & the NMDA Receptor 
 Excitotoxicity has been linked to many neurodegenerative states, including 
traumatic brain injury, ischemia/hypoxia, ALS, and is also thought to be involved in the 
degenerative effects of ethanol withdrawal.  The NMDA receptor has been the focus of 
much research in recent years and is thought to be a key factor in excitotoxicity, in part 
due to the receptor’s permeability to Ca2+.  An influx of Ca2+ can lead to the activation of 
many cell death enzymes, including endonucleases, proteases, and phospholipases 
(Sattler & Tymianski, 2000).  Recent research has also shown a propensity for dendritic 
degradation.  Following a short exposure to NMDA, dendritic swellings were found first 
in the distal branches and later in the more proximal dendritic branches (Hoskison, et al., 
2007).  The dendritic swelling was also accompanied by a time-dependent loss of 
immunoreactivity of the microtubule-associated protein MAP-2 in the dendrites of 
pyramidal cells (Hoskison, et al., 2007).  Also, decreased dendritic spines and a loss of 
filamentous actin has also been observed following a brief NMDA exposure, while over 
the same exposure period, staining for the presynaptic marker synapsin 1 as well as 
staining for PSD-95 and the NR1 subunit of the NMDA receptor remained stable 
(Halpain, et al., 1998).  In particular, the Ca2+-dependent protease calpain has been shown 
to cleave the cytoskeletal protein spectrin, resulting in two large protein breakdown 
products (BDPs; Vanderklish & Bahr, 2000).  These BDPs have been detected in vitro 
following as little as a 5 minute exposure to NMDA (Bahr, Tiriveedhi, Park, & Lynch, 
1995), while in vivo work has suggested that BDPs take many hours and even days to be 
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observed following NMDA-induced degeneration (Siman, et al., 1989).  However, there 
has been confusion regarding which markers might reflect calpain-mediated cell death 
and the timecourse associated with the expression of these markers remains unclear.  For 
example, previous research has indicated that calpain-dependent axonal varicosities 
appear prior to neuronal damage following glutamate-induced excitotoxic insult (Hou, et 
al., 2009).  Hence, previous research has produced many discrepancies regarding the 
manner in which neuronal degeneration occurs following NMDA-induced excitotoxic 
insult.  The present studies were designed to examine the time-dependent neuronal 
degradation produced by excessive NMDA receptor activation to elucidate the possible 
differences in the time course of dendritic and axonal injury as reflected by the magnitude 
of dendritic (NR1) or synaptic (synaptophysin) markers.   
 
Raw Control Values 
 The raw control levels of cytotoxicity as measured by PI uptake across time 
revealed that levels of PI uptake increase over time in the pyramidal cell layer of the CA1 
region and the granule cell layer of the DG.  This was in contrast to the decrease in PI 
uptake across time seen in the pyramidal cell layer of the CA3 region of the 
hippocampus.  This was unexpected as previous research has indicated that the CA1 
region contains a greater density of NMDA receptors as compared to the CA3 or DG 
(Butler, et al., 2010).  The lowest levels of PI uptake were seen in the DG region of the 
hippocampus across all timepoints examined.  This is in agreement with previous 
research indicating that the DG region has the greatest immunoreactivity of calbindin-
D28K compared to either the CA1 or CA3 regions (Prendergast, et al., 2001).  Calbindin-
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D28K is a Ca2+ binding protein which sequesters cytosolic Ca2+ for a period of time, 
protecting the cell from Ca2+-mediated cell death (Prendergast, et al., 2001).  The 
increase in arbitrary PI uptake over time in the CA1 seen in control-treated slices is 
possibly due to increased NMDA receptor activation caused by “medium-change” 
toxicity and an increase in glutamine, leading to increased glutamate concentrations 
(Mayer, et al., 2002a).  Glutamine present in the culture media has been shown to be 
contaminated with glutamate and also produce glutamate; both events are sufficient to 
produce toxicity associated with the medium change (Driscoll, Deibler, Law, & Crane, 
1993).  The increase in glutamate as a result of media change could also be responsible 
for the high levels of arbitrary PI uptake seen within the CA3 region of the hippocampus.  
The pyramidal call layer of the CA3 is thought to contain the greatest number of kainite 
receptors as compared to either the CA1 or DG regions (Martens & Wree, 2001).  
Further, treatment of kainite resulted in greater levels of toxicity in the CA3 compared to 
the CA1 or DG in organotypic hippocampal cultures (Holopainen, Jarvela, Lopez-Picon, 
Pelliniemi, & Kukko-Lukjanov, 2004).  Thus, it is possible that the influx of glutamate 
induced by the medium change first activated kainite receptors in the CA3 region and 
subsequently activated NMDA receptors in the CA1 region.  The very low levels of PI 
uptake seen in control-treated cultures is not unexpected as small amounts of toxicity 
may be attributed to the trauma induced by hippocampal removal, chopping the 
hippocampus into slices, as well as “medium-change” toxicity.   
Examining the raw control data for differences in region and exposure time 
revealed significantly greater immunoreactivity of the NR1 subunit of the NMDA 
receptor and the synaptic vesicle protein synaptophysin within the pyramidal cell layer of 
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the CA1 region of the hippocampus as compared to either the CA3 or DG regions.  
Previous research has indicated that the CA1 region may have a select vulnerability to 
excitotoxic insult as a result of increased mature neurons and functional NMDA receptors 
(Butler, et al., 2010).  Furthermore, recent research also suggests that exposure to NMDA 
results in higher Ca2+ concentrations and increased mitochondrial Ca2+ accumulation in 
the CA1 region of the hippocampus compared to the CA3 region (Stanika, Winters, 
Pivovarova, & Andrews, 2010).   Thus, the results of the present study may also suggest 
that more functional NMDA receptors are present in the CA1 region as opposed to the 
CA3 or DG regions of the hippocampus.  These results are consistent with previous 
research indicating decreased expression of NR2B in the CA3 and DG regions as 
compared to the CA1 region of the hippocampus (Coultrap, Nixon, Alvestad, Valenzuela, 
& Browning, 2005).  The expression of NR1 within the CA3 was also decreased in 
comparison to the CA1 (Coultrap, et al., 2005).  Previous research has also indicated that 
NR1 and NR2A, but not NR2B, subunit expression increases with age in culture (Brewer, 
et al., 2007); however, this effect was not observed in the present study.  Further, earlier 
research also revealed that protein levels as well as receptor surface expression for NR1, 
NR2A, and NR2B increased with age in cultures (Fogal, Trettel, Uliasz, Levine, & 
Hewett, 2005; Mizuta, Katayama, Watanabe, Mishina, & Ishii, 1998).  Though 
significant methodological differences between the studies could explain the discrepancy 
in NMDA receptor expression (i.e. primary vs. organotypic cultures, different DIV), it is 
nevertheless surprising that NR1 immunoreactivity within the CA1 region was not time-
dependent in the present study.   
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Immunoreactivity of the synaptic vesicle protein synaptophysin was also 
increased in the CA1 in comparison to the CA3 and DG and this effect was significantly 
potentiated with elevated exposure time.  Levels of synaptophysin immunoreactivity 
were similar between the DG and CA3, and immunoreactivity was increased similarly in 
both regions following 120 hour exposure to control conditions.  The perforant pathway 
in the brain provides largely unidirectional projections from the entorhinal cortex to the 
granule cell layer of the dentate gyrus, although the entorhinal cortex also projects 
directly to the other subfields of the hippocampal formation (i.e. CA1-CA3, subiculum).  
Mossy fibers connect the dentate gyrus to the CA3 pyramidal cell layer while projections 
from the CA3 (termed Schaffer collaterals) synapse onto CA1 pyramidal cells (for a 
review, see Knowles, 1992).   Fibers from the CA1 then project to the subiculum and 
finally out of the hippocampus and back to the entorhinal cortex.  The major input 
(perforant pathway) is clearly interrupted by use of the organotypic hippocampal cell 
culture model as hippocampal input from the entorhinal cortex is interrupted.  Previous 
research has suggested that a synaptic reorganization occurs in the organotypic 
hippocampal slice culture model used in the present set of experiments and that this 
reorganization lead to the production of new synaptic pathways between the CA1 and DG 
(Gutierrez & Heinemann, 1999; Mulholland & Prendergast, 2003).  Thus, the time-
dependent increase in synaptophysin immunoreactivity in all regions, and in particular 
the CA1 region, likely demonstrates enhanced synaptogensis following disruption of the 
afferent innervations to the dentate gyrus.  The increase in pre- and post-synaptic markers 
over time seen in the present study is consistent with previous in vitro work 
demonstrating increased expression of two synaptic marker proteins synaptophysin (pre-
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synaptic marker) and PSD-95 (post-synaptic marker) over the developmental period seen 
in the organotypic hippocampal slice culture model (Buckby, Mummery, Crompton, 
Beesley, & Empson, 2004; Mielke, et al., 2005).   
 
NMDA-induced cytotoxicity 
 A multitude of studies have revealed that the glutamate receptor agonist NMDA 
produces reliable toxicity as measured by propidium iodide uptake, neuron-specific 
nuclear protein (NeuN) immunoreacitivity (a measure of mature neurons), and fluoro-
jade B staining (a marker of neuronal loss; Butler, et al., 2010; Gibson, et al., 2003; Kim, 
Chang, Chen, Rapoport, & Rao, 2009; Mulholland, Self, Harris, Littleton, & Prendergast, 
2004; Wilkins, et al., 2006; Zimmer, et al., 2000).   The present results reveal a time-
dependent NMDA-induced increase in PI fluorescence within the CA1 region which 
peaked 24 hours following NMDA exposure.  Even though NMDA-induced PI 
fluorescence decreased at later timepoints, the level of PI uptake never returned to 
baseline levels seen with control-treated cultures.  These results are in partial agreement 
with previous research, which revealed significant increases in PI uptake assessed 1 day 
or 3 days following exposure, but not when PI was measured 5 or more days following 
NMDA exposure (Wilkins, et al., 2006).  A smaller, but still significant, increase in PI 
uptake (~200% control) was seen following 120 hour exposure to NMDA in the present 
study, which is in disagreement with the previously mentioned study (Wilkins, et al., 
2006).  However, significant methodological differences may be accountable for the 
differences observed.  For example, the cultures in the current study were exposed to 
NMDA continuously for 120 hours while other cultures were only exposed to NMDA for 
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1 hour and then transferred into fresh culture media (Wilkins, et al., 2006).  The cytotoxic 
effect of NMDA was significantly attenuated by the addition of the competitive NMDA 
receptor antagonist APV, suggesting that the toxicity seen is indeed dependent on the 
NMDA receptor activation.  Though significant interactions in the CA3 or DG regions 
were not found, cultures exposed to NMDA, collapsed across time in both regions, 
showed significant increases in PI fluorescence compared to control-treated cultures.  A 
significant effect of time was also found in the CA3 such that, collapsed across treatment 
groups, PI uptake was greater following 24 or 72 hour exposure compared to 120 hour 
exposure, agreeing with results found for the CA1 suggesting a time-dependent decrease 
of PI fluorescence.   
The present set of experiments used PI fluorescence as a measure of cytotoxicity.  
PI is an intercalating agent which binds to DNA by attaching between the bonds of 
various base pairs.  PI has been shown to reliably correlate with other markers of 
neuronal death and has been used as a dependable indicator of cell damage in the 
organotypic slice culture model (Noraberg, 2004; Zimmer, et al., 2000).  The current 
study investigated PI fluorescence over three timepoints, including 24, 72, and 120 hours.  
The decrease in NMDA-induced PI fluorescence over time may suggest that damaged or 
dead cells were engulfed by macrophages prior to the time-appropriate measurement of 
PI fluorescence.  Thus, a loss of PI uptake following extended exposure to NMDA may 
not suggest less initial death, but less fluorescence due to fewer visible dead or damaged 
cells.  Alternatively, an excitatory-induced increase in deoxyribonuclease (DNase), which 
cleaves the phosphodiester links in the DNA backbone, could also lead to a loss of PI 
signal as a result of the loss of base pairs (Marti & Fleck, 2004).  Furthermore, 
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endonuclease G (endoG) is a caspase-independent nuclease found in mitochondria (Li, 
Luo, & Wang, 2001).  During apoptosis, endoG is released from the mitochondria and 
cleaves chromatin DNA within the nucleus (Li, et al., 2001).  Previous research has 
indicated that levels of endoG rise following AMPA-induced excitotoxicity (Henne, et 
al., 2006), an effect which may generalize to glutamate-induced excitotoxicity.  Thus, 
there are several possible explanations for the loss of PI signal.  Additional markers of 
neuronal degradation used previously with the organotypic cell culture model may be of 
use in future studies to illuminate the results found in the present study.  For example, 
histological staining by Fluoro-Jade B labeling degenerating neurons, lactate 
dehydrogenase release in the culture medium labeling cell lysis, and Nissl stain labeling 
ribosomal RNA all correlate well with PI activity and are, alone, good measures of cell 
damage (Zimmer, et al., 2000).  Further, previous studies have also looked at the 
immunoreactivity of NeuN to measure healthy mature neurons and iummunoreactivity of 
the Ca2+-binding protein calbindin D28k (Calb) to quantify neuronal loss (Wilkins, et al., 
2006).   
 
NMDA-induced loss of NR1 immunoreactivity 
 Exposure to NMDA produced a significant time-dependent loss of NR1 
immunoreactivity in the CA1 region of the hippocampus.  Previous research with primary 
hippocampal cultured neurons has indicated that transcription of the NR1 subunit is 
downregulated following excitotoxic insult (Gascon, et al., 2005).  The results of the 
current study support the hypothesis that overactivation of the NMDA receptor produces 
a downregulation in NMDA receptor subunits.  It has previously been shown that NMDA 
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receptors desensitize very quickly; in fact, the inhibition of synaptic NMDA receptors in 
cultured hippocampal neurons is thought to be mediated by Ca2+ (Rosenmund, Feltz, & 
Westbrook, 1995; Rosenmund & Westbrook, 1993).  Thus, it is possible that initial 
overactivation of the NMDA receptor followed by desensitization and downregulation 
resulted in the time-dependent loss of NR1 subunit immunoreactivity.   
Alternatively, the NMDA-induced loss of NR1 immunoreactivity following 72 or 
120 hour exposure could signify the degradation of the dendrites of the cell.  This is 
supported by data from previous studies indicating that NMDA receptors are primarily 
found on the dendrites of post-synaptic receptors (Jones & Baughman, 1991).   In 
addition, exposure to glutamate induced a redistribution of the AMPA receptor subunit 
GluR1 but not the NMDA receptor subunit NR1 in primary hippocampal cultures, 
suggesting that a brief exposure to glutamate (100μM for 15 minutes) does not result in 
downregulation of the NMDA receptor (Lissin, Carroll, Nicoll, Malenka, & von Zastrow, 
1999).  Further, early (5-10 minute exposure) Ca2+-dependent NMDA-induced dendritic 
injury has been shown previously (Halpain, et al., 1998; Hoskison, et al., 2007).  
However, loss of dendrites as measured by NR1 immunoreactivity was not seen 
following 24 hour exposure to NMDA in the present study, suggesting a possible delay in 
NMDA-induced dendritic injury in organotypic hippocampal slice cultures.  Although 
several methodological differences exist between the previous studies and the current 
study, it is possible that the marker of dendritic injury used in the present study was not 
as sensitive to rapid NMDA-induced injury as markers used in prior experiments (i.e. use 
of fluorescent dyes to label the plasma membrane to look at branched dendrites, labeling 
of F-actin, and high-power magnification of MAP2 labeling).  
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A significant loss of NR1 immunoreactivity was not found in cultures treated for 
24 hours, but rather in cultures exposed for 72 or 120 hours.  The thickness of the 
cultured hippocampal slices could play a part in activating NMDA receptors at various 
depths, leading to an initial downregulation of NR1 subunit immunoreactivity seen only 
at certain depths.  The immunohistochemistry method used in the present study utilized 
an overall quantification of fluorescence within each region, not taking into account the 
thickness of the slice and the many layers of tissue.  Thus, while overall NR1 
immunoreactivity was not decreased following 24 hour exposure, it is possible that there 
was an undetectable reduction in NR1 immunoreactivity present at certain depths (i.e. the 
layers closer to the membrane insert) following 24 hour exposure.  One method to 
determine the extent to which the layers of tissue influence the overall fluorescence is 
confocal microscopy.  Confocal microscopy offers an advantage over the current method 
in that the fluorescence can be measured at various depths of the tissue, allowing for a 
more precise measurement of fluorescence.   
Past studies have also found a differential effect of synaptic versus extrasynaptic 
NMDA receptors (for a review, see Groc, Bard, & Choquet, 2009).  Importantly, synaptic 
NMDA receptors are tethered to the membrane by the scaffolding protein PSD-95, which 
interacts with the C terminal of NR2-containing receptors (Dong, Waxman, & Lynch, 
2004; Husi, Ward, Choudhary, Blackstock, & Grant, 2000).  NMDA receptors found at 
the synaptic level are thought to have a prosurvival effect when activated while 
extrasynaptic NMDA receptors may activate cell death pathways (Levine, Cepeda, & 
Andre, 2010).  Prosurvival synaptic NMDA receptors aid in survival via the induction of 
the activity of cyclic adenosine monophosphate (cAMP) response element-binding 
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protein (CREB) and brain-derived neurotrophic factor (BDNF) gene expression 
(Hardingham, Fukunaga, & Bading, 2002).  On the contrary, Ca2+ entry through 
extrasynaptic NMDA receptors promotes death by blocking BDNF expression via 
activation of a dominant CREB shut-off pathway (Hardingham, et al., 2002).  NMDA-
induced excitotoxicity has been shown to produce calpain-dependent cleavage of PSD-95 
as well as calpain-dependent cleavage of the C-terminal region in NR2A-containing 
receptors and subsequently uncouple the synaptic NMDA receptor from downstream 
survival pathways (Gascon, Sobrado, Roda, Rodriguez-Pena, & Diaz-Guerra, 2008).   
Calpain-dependent cleavage of NR2B-containing subunits has also been recognized 
(Simpkins, et al., 2003).  Thus, the present results may also indicate an uncoupling of 
synaptic NMDA receptors via NMDA-induced cleavage of PSD-95. 
While the majority of NMDA receptors have been found at the synapse (Jones & 
Baughman, 1991; Luo, et al., 2002; Mattson, Wang, & Michaelis, 1991), previous 
research has indicated that the NR2A subunit is found primarily within mature synaptic 
neurons (Thomas, Miller, & Westbrook, 2006) while NR2B-containing receptors are 
primarily extrasynaptic (Tovar & Westbrook, 1999).  Since the present studies use 
hippocampal slice cultures taken from immature rat pups, it is important to note that the 
NR2B subunit is the prominent subunit during early development, whereas NR2A 
predominates later in development (Tovar & Westbrook, 1999).  However, recent 
research suggests that both NR2A- and NR2B-containing receptors may be localized 
either synaptically or extrasynaptically (Thomas, et al., 2006).   
 
NMDA-induced loss of synaptophysin 
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 Exposure to NMDA also produced a time-dependent loss in the immunoreactivity 
of the synaptic vesicle protein synaptophysin in the CA1 region of the hippocampus.  
Although the NMDA-induced loss was significant at every timepoint examined, the loss 
was more pronounced following 72 or 120 hour exposure as compared to 24 hour 
exposure.  The NMDA-induced, time-dependent loss of synaptophysin immunoreactivity 
suggests axonal degradation that was exacerbated with increased exposure to NMDA.    
Specifically, activation of the Ca2+-dependent protease calpain is thought to produce cell 
death via breakdown of the cytoskeleton (Sattler & Tymianski, 2000; Siman & Noszek, 
1988).  Calpain-mediated cleavage of the membrane cytoskeletal protein spectrin 
produces BDPs, which are produced following NMDA receptor-mediated exctiotoxicity 
(Bahr, et al., 1995; Vanderklish & Bahr, 2000).  Thus, the results of the present study 
may suggest calpain-mediated breakdown of the cytoskeleton following excessive 
NMDA receptor activation.   
Activation of the NMDA receptor can also lead to activation of necrotic or 
apoptotic neuronal death, depending on the intensity of the insult (Bonfoco, Krainc, 
Ankarcrona, Nicotera, & Lipton, 1995).  The protease family of caspases, and in 
particular caspase-3, is thought to be involved in apoptotic cell death (for a review, see 
Chan & Mattson, 1999).  Activation of the executor protease caspase-3 has been shown 
to be dependent on the early activation of the Ca2+-dependent protease calpain following 
neonatal hypoxia-ischemia (Blomgren, et al., 2001).  However, intrastriatal injections of 
glutamate were shown to result in no caspase-3 activity but significant calpain activation 
relating to NMDA or non-NMDA receptor-mediated excitotoxicity (Del Rio, et al., 
2008).  In addition, activation of calpain but not caspase-3 was found in cerebellar 
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granule cells exposed to excitotoxic injury produced by nitric oxide (Volbracht, et al., 
2005).  Kainate acid-induced status epilepticus was also shown to produce spectrin BDPs 
in the hippocampus, while there was no evidence for caspase activation under the same 
conditions (Araujo, et al., 2008).  Thus, although caspase-dependent apoptotic neuronal 
death cannot be ruled out as a possibility, it is unlikely that caspase-3 is involved in the 
early loss of synaptophysin immunoreactivity.   
 
Timecourse of NMDA-induced neuronal death 
 In order to determine whether somatic or axonal injury (i.e. PI uptake or loss of 
synaptophysin immunoreactivity, respectively) occurs first, subsequent studies were 
conducted on cultures exposed to NMDA for less than 24 hours.  Results show that while 
PI uptake is increased following as little as 15 minute NMDA exposure, loss of 
synaptophsin was not found at the early timepoints examined. This suggests that the 
somatic injury may precede axonal degeneration as well as the loss of NR1 subunit 
immunoreactivity.  However, given the previous research indicating early changes in 
axonal and dendritic swellings as well as early loss of dendritic spines following 
excitotoxic insult (Halpain, et al., 1998; Hoskison, et al., 2007; Hou, et al., 2009; Ikegaya, 
et al., 2001; Mizielinska, Greenwood, Tummala, & Connolly, 2009), it is possible that the 
measures used in the present study were not sensitive enough to detect changes at the 
level of the individual neuron.  Thus, confocal microscopy might provide a useful tool in 
determining the sensitivity of the current measurements and aid in further characterizing 
the topographical nature of NMDA-induced neuronal death.   
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Conclusions and Future Directions 
 The current data suggest that axonal injury may precede dendritic degradation (or 
NR1 downregulation) in response to excessive NMDA receptor activation.  The loss of 
NR1 subunit immunoreactivity does not appear to be a useful marker of early cell 
damage.  Similarly, the loss of synaptophysin immunoreactivity appeared earlier than the 
NMDA-induced loss of NR1 subunits, but neither marker appeared prior to PI uptake.  
Thus, neither NR1 nor synaptophysin immunoreactivity appear to be a reliable indicator 
of early neuronal death or damage.  Confocal microscopy and various dendritic/axonal 
markers will be used to further assess the effects of NMDA-induced insult at the level of 
the individual neuron to determine which part of the cell is more vulnerable to early 
excitotoxic injury.  Future studies will also investigate the significance of calpain 
activation in the time-dependent neuronal death following excitotoxic NMDA injury 
using the calpain inhibitor MDL-28170.  Additional live animal studies will be conducted 
to determine if the results of the present in vitro study generalize to in vivo experiments.   
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